Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Basal Cell Carcinoma Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Topical Treatment 1.4.3 Hedgehog Pathway Inhibitor Therapy 1.4.4 Mohs Surgery 1.4.5 Other Surgeries 1.4.6 Other Treatments 1.5 Market by Application 1.5.1 Global Basal Cell Carcinoma Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Specialty Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Basal Cell Carcinoma Treatment Market Perspective (2015-2026) 2.2 Basal Cell Carcinoma Treatment Growth Trends by Regions 2.2.1 Basal Cell Carcinoma Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Basal Cell Carcinoma Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Basal Cell Carcinoma Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Basal Cell Carcinoma Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Basal Cell Carcinoma Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Basal Cell Carcinoma Treatment Players by Market Size 3.1.1 Global Top Basal Cell Carcinoma Treatment Players by Revenue (2015-2020) 3.1.2 Global Basal Cell Carcinoma Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Basal Cell Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Basal Cell Carcinoma Treatment Market Concentration Ratio 3.2.1 Global Basal Cell Carcinoma Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Basal Cell Carcinoma Treatment Revenue in 2019 3.3 Basal Cell Carcinoma Treatment Key Players Head office and Area Served 3.4 Key Players Basal Cell Carcinoma Treatment Product Solution and Service 3.5 Date of Enter into Basal Cell Carcinoma Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Basal Cell Carcinoma Treatment Historic Market Size by Type (2015-2020) 4.2 Global Basal Cell Carcinoma Treatment Forecasted Market Size by Type (2021-2026) 5 Basal Cell Carcinoma Treatment Breakdown Data by Application (2015-2026) 5.1 Global Basal Cell Carcinoma Treatment Market Size by Application (2015-2020) 5.2 Global Basal Cell Carcinoma Treatment Forecasted Market Size by Application (2021-2026) 6 USA 6.1 USA Basal Cell Carcinoma Treatment Market Size (2015-2020) 6.2 Basal Cell Carcinoma Treatment Key Players in USA (2019-2020) 6.3 USA Basal Cell Carcinoma Treatment Market Size by Type (2015-2020) 6.4 USA Basal Cell Carcinoma Treatment Market Size by Application (2015-2020) (2015-2020) (2015-2020) (2015-2020) (2015-2020) (2015-2020) (2015-2020) 7Key Players Profiles 7.1 Roche 7.1.1 Roche Company Details 7.1.2 Roche Business Overview and Its Total Revenue 7.1.3 Roche Basal Cell Carcinoma Treatment Introduction 7.1.4 Roche Revenue in Basal Cell Carcinoma Treatment Business (2015-2020)) 7.1.5 Roche Recent Development 7.2 Sun Pharmaceuticals 7.2.1 Sun Pharmaceuticals Company Details 7.2.2 Sun Pharmaceuticals Business Overview and Its Total Revenue 7.2.3 Sun Pharmaceuticals Basal Cell Carcinoma Treatment Introduction 7.2.4 Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) 7.2.5 Sun Pharmaceuticals Recent Development 7.3 Bausch Health Companies 7.3.1 Bausch Health Companies Company Details 7.3.2 Bausch Health Companies Business Overview and Its Total Revenue 7.3.3 Bausch Health Companies Basal Cell Carcinoma Treatment Introduction 7.3.4 Bausch Health Companies Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) 7.3.5 Bausch Health Companies Recent Development 7.4 Taro Pharmaceuticals 7.4.1 Taro Pharmaceuticals Company Details 7.4.2 Taro Pharmaceuticals Business Overview and Its Total Revenue 7.4.3 Taro Pharmaceuticals Basal Cell Carcinoma Treatment Introduction 7.4.4 Taro Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) 7.4.5 Taro Pharmaceuticals Recent Development 7.5 Mylan 7.5.1 Mylan Company Details 7.5.2 Mylan Business Overview and Its Total Revenue 7.5.3 Mylan Basal Cell Carcinoma Treatment Introduction 7.5.4 Mylan Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) 7.5.5 Mylan Recent Development 8Analyst's Viewpoints/Conclusions 9Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Disclaimer 9.3 Author Details

List of Tables Table 1. Basal Cell Carcinoma Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Basal Cell Carcinoma Treatment Revenue Table 3. Ranking of Global Top Basal Cell Carcinoma Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Basal Cell Carcinoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Topical Treatment Table 6. Key Players of Hedgehog Pathway Inhibitor Therapy Table 7. Key Players of Mohs Surgery Table 8. Key Players of Other Surgeries Table 9. Key Players of Other Treatments Table 10. Global Basal Cell Carcinoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global Basal Cell Carcinoma Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global Basal Cell Carcinoma Treatment Market Size by Regions (2015-2020) (US$ Million) Table 13. Global Basal Cell Carcinoma Treatment Market Share by Regions (2015-2020) Table 14. Global Basal Cell Carcinoma Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global Basal Cell Carcinoma Treatment Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. Basal Cell Carcinoma Treatment Market Growth Strategy Table 20. Main Points Interviewed from Key Basal Cell Carcinoma Treatment Players Table 21. Global Basal Cell Carcinoma Treatment Revenue by Players (2015-2020) (Million US$) Table 22. Global Basal Cell Carcinoma Treatment Market Share by Players (2015-2020) Table 23. Global Top Basal Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Treatment as of 2019) Table 24. Global Basal Cell Carcinoma Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Basal Cell Carcinoma Treatment Product Solution and Service Table 27. Date of Enter into Basal Cell Carcinoma Treatment Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Basal Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$) Table 30. Global Basal Cell Carcinoma Treatment Market Size Share by Type (2015-2020) Table 31. Global Basal Cell Carcinoma Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Basal Cell Carcinoma Treatment Market Size Share by Application (2015-2020) Table 33. Global Basal Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$) Table 34. Global Basal Cell Carcinoma Treatment Market Size Share by Application (2021-2026) Table 35. USA Key Players Basal Cell Carcinoma Treatment Revenue (2019-2020) (Million US$) Table 36. USA Key Players Basal Cell Carcinoma Treatment Market Share (2019-2020) Table 37. USA Basal Cell Carcinoma Treatment Market Size by Type (2015-2020) (Million US$) Table 38. USA Basal Cell Carcinoma Treatment Market Share by Type (2015-2020) Table 39. USA Basal Cell Carcinoma Treatment Market Size by Application (2015-2020) (Million US$) Table 40. USA Basal Cell Carcinoma Treatment Market Share by Application (2015-2020) Table 41. Roche Company Details Table 42. Roche Business Overview Table 43. Roche Product Table 44. Roche Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) (Million US$) Table 45. Roche Recent Development Table 46. Sun Pharmaceuticals Company Details Table 47. Sun Pharmaceuticals Business Overview Table 48. Sun Pharmaceuticals Product Table 49. Sun Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) (Million US$) Table 50. Sun Pharmaceuticals Recent Development Table 51. Bausch Health Companies Company Details Table 52. Bausch Health Companies Business Overview Table 53. Bausch Health Companies Product Table 54. Bausch Health Companies Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) (Million US$) Table 55. Bausch Health Companies Recent Development Table 56. Taro Pharmaceuticals Company Details Table 57. Taro Pharmaceuticals Business Overview Table 58. Taro Pharmaceuticals Product Table 59. Taro Pharmaceuticals Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) (Million US$) Table 60. Taro Pharmaceuticals Recent Development Table 61. Mylan Company Details Table 62. Mylan Business Overview Table 63. Mylan Product Table 64. Mylan Revenue in Basal Cell Carcinoma Treatment Business (2015-2020) (Million US$) Table 65. Mylan Recent Development Table 66. Research Programs/Design for This Report Table 67. Key Data Information from Secondary Sources Table 68. Key Data Information from Primary Sources List of Figures Figure 1. Global Basal Cell Carcinoma Treatment Market Share by Type: 2020 VS 2026 Figure 2. Topical Treatment Features Figure 3. Hedgehog Pathway Inhibitor Therapy Features Figure 4. Mohs Surgery Features Figure 5. Other Surgeries Features Figure 6. Other Treatments Features Figure 7. Global Basal Cell Carcinoma Treatment Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Specialty Clinics Case Studies Figure 10. Others Case Studies Figure 11. Basal Cell Carcinoma Treatment Report Years Considered Figure 12. Global Basal Cell Carcinoma Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global Basal Cell Carcinoma Treatment Market Share by Regions: 2020 VS 2026 Figure 14. Global Basal Cell Carcinoma Treatment Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global Basal Cell Carcinoma Treatment Market Share by Players in 2019 Figure 17. Global Top Basal Cell Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Basal Cell Carcinoma Treatment as of 2019 Figure 18. The Top 10 and 5 Players Market Share by Basal Cell Carcinoma Treatment Revenue in 2019 Figure 19. USA Basal Cell Carcinoma Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 21. Roche Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2015-2020) Figure 22. Sun Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Sun Pharmaceuticals Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2015-2020) Figure 24. Bausch Health Companies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Bausch Health Companies Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2015-2020) Figure 26. Taro Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Taro Pharmaceuticals Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2015-2020) Figure 28. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Mylan Revenue Growth Rate in Basal Cell Carcinoma Treatment Business (2015-2020) Figure 30. Bottom-up and Top-down Approaches for This Report Figure 31. Data Triangulation Figure 32. Key Executives Interviewed

Roche Sun Pharmaceuticals Bausch Health Companies Taro Pharmaceuticals Mylan